- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05645614
Anxiety and Pain During Intervention for Abortion Under Local Anesthesia (ADIAL)
Retrospective Evaluation of Pain and Anxiety in Standard Routine Care During Abortion Under Local Anesthesia, in an Abortion Center
Study Overview
Detailed Description
Voluntary interruption of pregnancy corresponds to a social demand. The French National Authority for Health recommends that any woman wishing to have a surgical abortion should have the choice between general anesthesia and local anesthesia. The advantages of local anesthesia are its simplicity and safety; the disadvantages are that the state of consciousness during the procedure may be associated with anxiety, and the perception of persistent pain despite the local anesthesia.
The majority of patients express pain during the procedure. Anxiety may be a major predictor of pain during the procedure. Moreover, beyond its possible involvement in pain, anxiety is also a factor of patient discomfort in its own right.
The 10-point verbal numerical scale was used for assessing pain and anxiety. The State Trait Anxiety Inventory (STAI), a 20-item anxiety scale, is also used as a reference to measure anxiety. This scale is carried out for patients undergoing an abortion under local anesthesia in the department.
Other factors could have an impact on the level of pain : age, pregnancy term, parity, history of dysmenorrhea, history of domestic violence or sexual violence.
The investigator team conduct a retrospective analysis in a cohort of patients who underwent an abortion under local anaesthesia in the obstetrics gynecology department of La Pitié Salpêtrière, analyzing their level of pain before, during and after the intervention The secondary objective is to analyze their anxiety level. Age, term of pregnancy, parity, history of dysmenorrhea, history of violence will be analyzed as potential predictive factors of pain.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Salignon Alexandra, MD
- Phone Number: +33 142165762
- Email: louise-laure.mariani@aphp.fr
Study Contact Backup
- Name: Mariani Louise Laure, MD,PH
- Phone Number: +33 142165762
- Email: louise-laure.mariani@aphp.fr
Study Locations
-
-
-
Paris, France, 75013
- Recruiting
- Hôpital Pitié Salpêtrière
-
Contact:
- MARIANI Louise Laure, MD
- Phone Number: +33 142165762
- Email: louise-laure.mariani@aphp.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- patients who need an abortion under local anesthesia
- Women who speak and read French
Exclusion Criteria:
- NA
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain level of the patient before, during and after (10min post surgery) the abortion procedure under local anesthesia.
Time Frame: 3 hours
|
Evolution of pain over time (from preoperative to postoperative), self-assessed on a numerical scale from 0 to 10
|
3 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anxiety level of the patient before, during and after (10min post surgery) the abortion procedure under local anesthesia.
Time Frame: 3 hours
|
Evolution of Anxiety over time (from preoperative to postoperative), self-assessed on a numerical scale from 0 to 10
|
3 hours
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- APHP220368
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.